Advanced search×

Reasons for and management of postvitrectomy vitreous hemorrhage in proliferative diabetic retinopathy.

Hua H Yan, Jing J Cui, Yingjuan Y Lu, Jinguo J Yu, Song S Chen, and Yinghai Y Xu

Curr Eye Res 35(4):308-13 (2010) PMID 20373898

To analyze the reasons for postvitrectomy vitreous hemorrhage in proliferative diabetic retinopathy (PDR), and to evaluate the effects of retreatment. Design: Retrospective, nonrandomized, observational case series.

DOI: 10.3109/02713680903572491
Version: za2963e q8zae q8zb2 q8zc0 q8zd7 q8zef q8zff q8zg4

Similar articles you may find interesting…

  1. Revascularization versus medical therapy for renal-artery stenosis.
    , Keith K Wheatley, ... John J Scoble

    361(20):1953-62 (2009) PMID 19907042

    We found substantial risks but no evidence of a worthwhile clinical benefit from revascularization in patients with atherosclerotic renovascular disease. (Current Controlled Trials number, ISRCTN59586944.) 2009 Massachusetts Medical Society...
    PDF not found
  2. Faster visual recovery after 23-gauge vitrectomy compared with 20-gauge vitrectomy.
    Raja Narayanan, Anshuman Sinha, ... Baruch D Kuppermann

    Retina 30(9):1511-4 (2010) PMID 20829739

    To evaluate whether 23-gauge (23 G) pars plana vitrectomy is associated with earlier visual recovery compared with standard 20-gauge (20 G) pars plana vitrectomy. Retrospective chart review of patients who underwent pars plana vitrectomy for various indications was performed. Thirty consecutive eyes...
  3. [Experimental study on treatment of rabbits optic nerve injury with Caspase-3 inhibitor z-DEVD-fmk].
    Wei W Zhang, Jin-guo JG Yu, ... Hua H Yan

    Zhonghua Yan Ke Za Zhi 46(12):1084-9 (2010) PMID 21211221

    At the 7(th) day after treatment, the latency of F-VEP P(1) in experimental group was shorter than that in the control group [(90.50 ± 7.61) ms vs (113.59 ± 12.92) ms, t = 4.060, P < 0.05] and the number of retinal ganglion cells (RGC) in the experimental group was greater than that in the control...